Helaina
New York-based biotech company producing human proteins externally
Helaina was founded in 2019 by CEO Laura Katz, inspired by the challenges mothers face in accessing breast milk's unique nutritional benefits. Katz envisioned a solution where bioactive compounds, like those in breast milk, could be produced and scaled for broader health applications. Helaina’s mission centres on creating impactful, multifunctional nutrients for people at every life stage.
Through extensive research and thousands of lab experiments, the team developed a breakthrough technology to produce human proteins outside the body. Their first product, effera™, a human lactoferrin protein, was tested for safety and is poised to revolutionize nutrition for both babies and adults. Helaina’s innovative platform aims to redefine human health with a new class of bioactive nutrients.
Visit website: https://www.myhelaina.com/
Details last updated 01-Oct-2024
Helaina News
Helaina secures $45m to boost production of anti-ageing protein
Longevity Technology - 27-Sep-2024
Biotech advances human lactoferrin for better health and longevity
Read more...